title: Reactions following completion of 1 and 2 year multidrug therapy (MDT).
abstract: We evaluated the incidence, severity, and duration of reactional states in 139 multibacillary (MB) leprosy patients in the first 2 years after the completion of the 1 year regimen of multidrug therapy (MDT) currently recommended by the World Health Organization (WHO) and compared those findings with 295 MB leprosy patients treated with the same regimen previously recommended for 2 years. During the first year after the completion of 1 year MDT, patients experienced 1 or more reactional states 27% of the time, the vast majority being lepra type 1 reactions (reversal reactions, RR), whereas patients who received 2 year MDT experienced a reactional state during that time period only 8% of the time (P < 0.001). Furthermore, during the first year after the completion of therapy, and during the first 2 years, both the number of reactional states and reversal reactions were significantly (P < or = 0.004) more frequent, severe, of longer duration, and more commonly associated with neuritis.
authors.affiliation: Leonard Wood Memorial Center for Leprosy Research, Cebu City, Philippines.
authors.forename: Ma Victoria F
authors.initials: MV
authors.lastname: Balagon
authors.forename: Robert H
authors.initials: RH
authors.lastname: Gelber
authors.forename: Rodolfo M
authors.initials: RM
authors.lastname: Abalos
authors.forename: Roland V
authors.initials: RV
authors.lastname: Cellona
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D055815:Young Adult
chemical_list: D007917:Leprostatic Agents
references.citation: World Health Organ Tech Rep Ser. 1982;675:1-33
references.pmid: 6806990
references.citation: Int J Lepr Other Mycobact Dis. 1995 Jun;63(2):195-201
references.pmid: 7602214
references.citation: Lepr Rev. 1996 Dec;67(4):253-9
references.pmid: 9033196
references.citation: Int J Lepr Other Mycobact Dis. 1991 Jun;59(2):255-61
references.pmid: 2071983
references.citation: J Immunol. 1984 Jun;132(6):3085-90
references.pmid: 6327818
references.citation: Int J Lepr Other Mycobact Dis. 1995 Mar;63(1):18-22
references.pmid: 7730714
references.citation: Lepr Rev. 2000 Sep;71(3):318-24
references.pmid: 11105490
references.citation: Lepr Rev. 1994 Dec;65(4):320-32
references.pmid: 7861918
references.citation: J Exp Med. 1989 May 1;169(5):1565-81
references.pmid: 2523952
references.citation: Clin Exp Immunol. 1991 Apr;84(1):103-8
references.pmid: 2015700
references.citation: Clin Exp Immunol. 1995 Feb;99(2):196-202
references.pmid: 7851011
references.citation: Int J Lepr Other Mycobact Dis. 2004 Dec;72(4):493-500
references.pmid: 15755209
references.citation: Int J Lepr Other Mycobact Dis. 1999 Mar;67(1):6-12
references.pmid: 10407623
references.citation: Infect Immun. 2001 May;69(5):3413-7
references.pmid: 11292765
references.citation: Int J Lepr Other Mycobact Dis. 1996 Dec;64(4 Suppl):S21-8
references.pmid: 9030120
references.citation: Lepr Rev. 2000 Jun;71(2):144-53
references.pmid: 10920610
references.citation: Int J Lepr Other Mycobact Dis. 1998 Jun;66(2):159-69
references.pmid: 9728448
references.citation: Clin Exp Immunol. 1976 Apr;24(1):157-67
references.pmid: 820499
references.citation: Lepr Rev. 2000 Sep;71(3):309-17
references.pmid: 11105489
references.citation: World Health Organ Tech Rep Ser. 1998;874:1-43
references.pmid: 9627517
references.citation: Clin Exp Immunol. 1986 Aug;65(2):253-9
references.pmid: 2431817
references.citation: Int J Lepr Other Mycobact Dis. 2004 Jun;72(2):125-33
references.pmid: 15301592
references.citation: Lepr Rev. 1994 Sep;65(3):190-203
references.pmid: 8942150
references.citation: Clin Exp Immunol. 2002 May;128(2):333-8
references.pmid: 11985524
references.citation: Lancet. 1969 Nov 1;2(7627):933-5
references.pmid: 4186599
references.citation: Lepr Rev. 1998 Sep;69(3):225-34
references.pmid: 9805878
references.citation: Int J Lepr Other Mycobact Dis. 2003 Dec;71(4):308-19
references.pmid: 14763888
references.citation: Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):8-15
references.pmid: 8326184
references.citation: Lepr Rev. 1994 Mar;65(1):9-33
references.pmid: 8201838